Current health sciences journal最新文献_第8页

Clinical and Demographic Profiling of Periodontal Diseases: A Retrospective Analysis Using the 2018 Periodontal Classification Algorithm. 牙周病的临床和人口学特征：使用 2018 年牙周病分类算法的回顾性分析。

Current health sciences journal Pub Date : 2024-01-01 Epub Date: 2024-03-31 DOI: 10.12865/CHSJ.50.01.04

Dorin Nicolae Gheorghe, Flavia Mirela Nicolae, Dora Maria Popescu, Sergiu Ciobanu, Petra Surlin

{"title":"Clinical and Demographic Profiling of Periodontal Diseases: A Retrospective Analysis Using the 2018 Periodontal Classification Algorithm.","authors":"Dorin Nicolae Gheorghe, Flavia Mirela Nicolae, Dora Maria Popescu, Sergiu Ciobanu, Petra Surlin","doi":"10.12865/CHSJ.50.01.04","DOIUrl":"10.12865/CHSJ.50.01.04","url":null,"abstract":"The research presented in this retrospective study aimed to investigate the prevalence of periodontal diseases within a population and explore potential demographic and clinical variations among patients diagnosed with periodontitis. The study involved the analysis of 104 patient records from the Periodontology Clinic at the University of Medicine and Pharmacy in Craiova, collected between 2018 and 2019. Utilizing the 2018 classification algorithm for periodontal diseases, patients were categorized into three groups: a control group without periodontal issues (Group H), a gingivitis group (Group G), and a periodontitis group (Group P). The collected data encompassed demographic information, oral hygiene indicators, and clinical parameters. Statistical analysis and graphical representation revealed notable trends, such as the higher prevalence of periodontitis (51%) compared to gingivitis (14%), with 35% of participants showing no signs of periodontal involvement. Detailed group analyses highlighted specific patterns, including a substantial male predominance among patients without periodontal issues and varying distributions of periodontal stages based on gender. Additionally, the study explored age-related variations, revealing an increasing average age from the control group (33.04 years) to the gingivitis group (34.86 years) and a significant rise in the periodontitis group (45.49 years). The findings underscore the importance of early detection and intervention in periodontal diseases and provide valuable insights for clinicians in tailoring individualized diagnostic and treatment approaches.","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"50 1","pages":"29-35"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11151948/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141285636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

In vitro Assessment of Free Radical Scavenging Effect and Thermal Protein Denaturation Inhibition of Bee Venom for an Anti-Inflammatory Use. 体外评估蜂毒的自由基清除效果和热蛋白变性抑制作用，以用于抗炎。

Current health sciences journal Pub Date : 2024-01-01 Epub Date: 2024-03-31 DOI: 10.12865/CHSJ.50.01.11

Camelia Alina Gîlcescu Florescu, Elena Camelia Stanciulescu, Anca Berbecaru-Iovan, Roxana Maria Balasoiu, Catalina Gabriela Pisoschi

引用次数: 0

Carcinoembryonic Antigen CEA - Prognostic Value in Immediate Post-Operative Mortality in Colorectal Cancer. 癌胚抗原 CEA - 对结直肠癌术后即刻死亡率的预后价值。

Current health sciences journal Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.14

Andreea Firut, Sorin Scurtu, Michael Schenker, Nicoleta Gadea, Ana Maria Patrascu, Vlad Padureanu, Stefan Patrascu, Valeriu Surlin

{"title":"Carcinoembryonic Antigen CEA - Prognostic Value in Immediate Post-Operative Mortality in Colorectal Cancer.","authors":"Andreea Firut, Sorin Scurtu, Michael Schenker, Nicoleta Gadea, Ana Maria Patrascu, Vlad Padureanu, Stefan Patrascu, Valeriu Surlin","doi":"10.12865/CHSJ.49.04.14","DOIUrl":"10.12865/CHSJ.49.04.14","url":null,"abstract":"Introduction: This study investigates the prognostic significance of carcinoembryonic antigen (CEA) levels in predicting early postoperative mortality in patients who have undergone colorectal cancer surgery.Methods: Between 2017 and 2022, total of 325 patients were enrolled in the study, and their preoperative serum CEA levels were measured. Relevant clinical and operative data were extracted and correlations between CEA levels and postoperative mortality was analysed.Results: Among the surgical cases, 180 patients (55.3%) exhibited elevated CEA levels. Within the early postoperative period of 30 days, 14 patients (4.3%) succumbed, comprising 8 cases (2.4%) of colon cancer and 6 cases (1.8%) of rectal cancer. Notably, only 3 cases (0.9%), consisting of 1 (0.3%) colon cancer and 2 (0.6%) rectal cancer cases, were associated with an elevated CEA level. However, no statistically significant correlations were observed between CEA levels and early postoperative mortality.Conclusions: Our findings indicate that increased CEA levels may not serve as a reliable non-invasive marker for identifying patients at high risk of early mortality in the context of colo-rectal cancer surgery.","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"49 4","pages":"579-583"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976198/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140338247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Predictive Value of Pulmonary Involvement in Stroke Patients Co-Infected with COVID-19. 合并感染 COVID-19 的中风患者肺部受累的预测价值。

Current health sciences journal Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.9

Elena Anca Pinosanu, Emilia Burada, Denisa Pirscoveanu, Madalina Aldea, Carmen Valeria Albu, Roxana Surugiu, Raluca Elena Sandu

引用次数: 0

Update in LV Only Fusion CRT Pacing: Annals and Future Perspectives. 仅左心室融合 CRT 起搏的最新进展：年鉴与未来展望

Current health sciences journal Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.01

Andra Gurgu, Lucian Petrescu, Constantin Tudor Luca, Cristina Văcărescu, Georgică Târtea, Emilia-Violeta Goanță, Liviu Cirin, Dragoș Cozma

{"title":"Update in LV Only Fusion CRT Pacing: Annals and Future Perspectives.","authors":"Andra Gurgu, Lucian Petrescu, Constantin Tudor Luca, Cristina Văcărescu, Georgică Târtea, Emilia-Violeta Goanță, Liviu Cirin, Dragoș Cozma","doi":"10.12865/CHSJ.49.04.01","DOIUrl":"10.12865/CHSJ.49.04.01","url":null,"abstract":"Triple-chamber cardiac devices are utilized for cardiac resynchronization therapy (CRT) and is the standard-of-care therapy for heart failure (HF) patients in the current guidelines. In the setting of biventricular (BIV) pacing it involves a mandatory implantation of right ventricular (RV) lead that allows simultaneous BIV pacing with 0 ms VV (ventricular to ventricular) interval. Nevertheless, it seems that response to CRT is not related to RV lead position. RV pacing is known for deleterious effects on RV/Left Ventricle (LV) function and should not be used in persons with normal atrioventricular conduction (AV) and sinus rhythm. As it compensates for the additional asynchrony induced by unnecessary stimulation of RV pacing, only pacing the left ventricle (LV) may result in improved cardiac resynchronization therapy (CRT) outcomes and a decrease in the number of individuals who do not respond to the procedure. Furthermore, leadless LV fusion CRT pacing without RV lead could be a potential CRT therapy alternative to BIV pacing in nonischemic heart failure patients with preserved AV conduction. The aim of our study is to made an update in cardiac resynchronization therapy with LV only fusion pacing.","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"49 4","pages":"479-486"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976202/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140338272","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Holographic Techniques as a Novel Method for Intervention Planning: A Tertiary Centres Experience. 全息技术作为干预规划的新方法：一个高等教育中心的经验。

Current health sciences journal Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.15

Angelo Fabio D'Aiello, Ludovica Bognoni, Francesca Bevilacqua, Diana Gabriela Negura, Paolo Ferrero, Angelo Micheletti, Alessandro Giamberti, Sebastian Militaru, Constantin Militaru, Massimo Chessa

引用次数: 0

The Role of Neutrophil to Lymphocyte Ratio in the Assessment and Rehabilitation of Knee Osteoarthritis Patients. 中性粒细胞与淋巴细胞比率在膝骨关节炎患者评估和康复中的作用

Current health sciences journal Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.10

Ovidiu-Florin Fugaru, Mircea-Sebastian Șerbănescu, Magdalena Rodica Trăistaru

{"title":"The Role of Neutrophil to Lymphocyte Ratio in the Assessment and Rehabilitation of Knee Osteoarthritis Patients.","authors":"Ovidiu-Florin Fugaru, Mircea-Sebastian Șerbănescu, Magdalena Rodica Trăistaru","doi":"10.12865/CHSJ.49.04.10","DOIUrl":"10.12865/CHSJ.49.04.10","url":null,"abstract":"Osteoarthritis (OA) is considered to be a real problem for many people. The last decade is characterized through an increased interest in using a non-specific, simply and readily available marker of inflammation-neutrophil to lymphocyte ratio (NLR)-to predict various chronic diseases (gastrointestinal and colorectal cancers, lung cancer, cardiovascular events, sarcoidosis, arthritis). The aim of our study is to establish the correlation between NLR and other parameters of clinical and functional status in KOA patients and to compare the NLR values before and after rehabilitation program. 90 patients, aged 40 to 82 years, diagnosed with mild (8 patients), moderate (70 patients) and severe (12 patients) KOA, in accordance with Kellgren and Lawrence score. Statistical assessment showed different values for the erythrocyte sedimentation (ESR) rate at 1-hour, Visual Analogue Scale (VAS), and Lequesne index in the studied group. NLR regression was significant for ESR at 1 and 2 hours. As an independent diagnostic marker, NLR has limited value, however it can be considered an inexpensive additional biomarker for the diagnosis of KOA and for monitoring the rehabilitation program.","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"49 4","pages":"546-554"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976220/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140338270","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Aflibercept Versus Bevacizumab as First-Line Therapy in Age-Related Macular Degeneration. Aflibercept 与贝伐珠单抗作为老年性黄斑变性的一线疗法。

Current health sciences journal Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.4

Mădălina-Casiana Palfi Salavat, Edward Paul Șeclăman, Andreea-Alexandra Mușat, Mădălina Borugă, Cristina Patoni, Marius-Nicolae Popescu, Oana Elena Teodorescu, Ovidiu Mușat, Stella Ioana Popescu Patoni

{"title":"Aflibercept Versus Bevacizumab as First-Line Therapy in Age-Related Macular Degeneration.","authors":"Mădălina-Casiana Palfi Salavat, Edward Paul Șeclăman, Andreea-Alexandra Mușat, Mădălina Borugă, Cristina Patoni, Marius-Nicolae Popescu, Oana Elena Teodorescu, Ovidiu Mușat, Stella Ioana Popescu Patoni","doi":"10.12865/CHSJ.49.04.4","DOIUrl":"10.12865/CHSJ.49.04.4","url":null,"abstract":"Background: AMD (age-related macular degeneration) is the main cause of central vision loss in the population over 60 years old. AMD does not affect peripheral vision and complete blindness does not occur, instead, central vision is affected both for distance and for near. The purpose of this study is to evaluate the neovascular form of AMD treatment and compare ocular and systemic effects after intravitreal injection of aflibercept, respectively after bevacizumab when administered in comparable dosages and regimens. We conducted a retrospective, single-center study from June 2021 to December 2022 and enrolled 20 patients with neovascular AMD who had not received any prior treatment for this condition. We randomly assigned them to two groups of 10: group one received aflibercept and group two received bevacizumab as intravitreal injections under aseptic conditions. We excluded 2 patients who did not meet the criteria and ended up with two groups of 9 patients who received monocular treatment. We gave the patients 3 monthly injections of anti-VEGF agent and followed them up at 1 month, 3 months, and 9 months after the treatment. We assessed their visual acuity, intraocular pressure and OCT appearance at each follow-up visit. The primary outcome was visual acuity. All 18 patients included in the study reported an improvement in visual acuity after the intervention. When comparing the two anti-VEGF agents, data revealed the effect of aflibercept was prompter and more long-lasting. Areas of retinal ischemia appeared in both cases. However, they were observed faster in the case of patients treated with aflibercept. Thus, neovascular AMD is a disease that occurs with age, it can be early detected by OCT and slowed the progression to central blindness with intravitreal treatment.","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"49 4","pages":"503-509"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976211/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140338245","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

ELTD1 Review: New Regulator of Angiogenesis in Glioma. ELTD1 回顾：胶质瘤血管生成的新调节器

Current health sciences journal Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.03

Iuliana Buzatu, Daniela Elise Tache, Elena Victoria Manea Carneluti, Ovidiu Zlatian

{"title":"ELTD1 Review: New Regulator of Angiogenesis in Glioma.","authors":"Iuliana Buzatu, Daniela Elise Tache, Elena Victoria Manea Carneluti, Ovidiu Zlatian","doi":"10.12865/CHSJ.49.04.03","DOIUrl":"10.12865/CHSJ.49.04.03","url":null,"abstract":"Glioblastoma (GBM) is a severe brain cancer in which angiogenesis is controlled by G protein-coupled receptors (GPCRs), such as Epidermal Growth Factor Latrophilin and seven transmembrane domain-containing protein 1 (ELTD1), which are crucial for tumor progression. ELTD1 is an understudied GPCR with a broad expression profile in various tissues, including the human brain, especially in the cerebral cortex. It plays a significant role in angiogenesis and tumorigenesis and is regulated by interconnected VEGF and DLL4/Notch pathways. ELTD1 also modulates the JAK/STAT3/HIF-1α signaling axis, affecting the response of cells to low-oxygen conditions and promoting cell proliferation. However, their specific ligands and functional mechanisms remain unclear. ELTD1 expression is associated with different outcomes in various cancers. For example, in GBM, higher ELTD1 levels are linked to more mature and less leaky blood vessels, potentially enhancing drug delivery and therapeutic success. It also has divergent prognostic implications in renal, ovarian, and colorectal cancer. Additionally, ELTD1 overexpression in central nervous system endothelial cells suggests that it is a potential biomarker for multiple sclerosis. Therapeutically, blocking ELTD1 inhibits vessel formation, possibly slowing tumor growth. Initial therapies used polyclonal antibodies, but the shift has been towards more targeted monoclonal antibodies, particularly in preclinical glioma models. This review aimed to translate these insights into effective clinical treatments. However, several gaps remain in our knowledge regarding ELTD1 ligands and their potential involvement in other physiological or pathological processes that future research can address to elucidate the role of ELTD1 in cancer, through angiogenesis and other intracellular pathways.","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"49 4","pages":"495-502"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976199/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140338249","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Factors Associated with Stroke in Atrial Fibrillation. A Retrospective Study. 心房颤动患者中风的相关因素。回顾性研究。

Current health sciences journal Pub Date : 2023-10-01 Epub Date: 2023-12-29 DOI: 10.12865/CHSJ.49.04.13

Ciprian Rachieru, Daniel-Florin Lighezan, Lucian Petrescu, Elena-Anca Tartea, Emilia Violeta Goanta, Roxana Buzas, Dragos Cozma

{"title":"Factors Associated with Stroke in Atrial Fibrillation. A Retrospective Study.","authors":"Ciprian Rachieru, Daniel-Florin Lighezan, Lucian Petrescu, Elena-Anca Tartea, Emilia Violeta Goanta, Roxana Buzas, Dragos Cozma","doi":"10.12865/CHSJ.49.04.13","DOIUrl":"10.12865/CHSJ.49.04.13","url":null,"abstract":"Aim: The aim of our study was to retrospectively evaluate known factors such as CHA2DS2-VASc, but, also, new factors (such as left atrial remodeling), associated with the development of stroke in patients with atrial fibrillation (AFi).Material and methods: We performed a retrospective study in which 251 patients with AFi were included. 47 patients had an ischemic stroke before the diagnosis of AFi, at the time of diagnosis or after AFi was diagnosed. The CHA2DS2-VASc score was analyzed for all patients together with other left atrial remodeling parameters.Results: We observed that among the patients with ischemic stroke approximately 61.70% were over 72.5 years old compared to those without stroke who presented this age in a proportion of only 44.61% (OR=2.001, P=0.0367). The CHA2DS2-VASc score had the greatest statistical impact for stroke, as expected. Patients with a CHA2DS2-VASc score >4.5 presented stroke in a proportion of 87.23% compared to CHA2DS2-VASc <4.5 who had stroke only in a proportion of 12.77% (OR=11.51, P=<0.0001). Regarding left atrial remodeling parameters, low LA ejection fraction was associated with a high percentage of stroke among patients (61.70%) compared to those with LA EF>34.5% who had stroke only in a percentage of 38.30% (OR= 2.124, P=0.0238).Conclusions: Although the CHA2DS2-VASc score remains a good factor for predicting the association of AFi with ischemic stroke, echocardiographic parameters for the evaluation of the left atrium can be used as new risk factors for predicting the occurrence of ischemic stroke in patients with AFi.","PeriodicalId":93963,"journal":{"name":"Current health sciences journal","volume":"49 4","pages":"571-578"},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10976215/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140338250","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0